BVMF/ABTT34 (BVMF/ABTT34)

Brazil Stock Exchange: BVMF/ABTT34 · BRL

R$46.1

-1.04 (-2.2%)· Recorded snapshot

Market cap	953.9B
Revenue (ttm)	249.8B
Net income (ttm)	24.2B
EPS (ttm)	R$1.20
P/E (trailing)	38.4x
P/E (forward)	17.5x
Dividend	R$0.72 (1.57%)
Volume	87
Beta	0.58

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 249.8B
Net income (ttm): 24.2B
EPS (ttm): R$1.20
P/E (trailing): 38.4x
P/E (forward): 17.5x
Market cap: 953.9B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E17.5

P25 n/aP50 n/aP75 n/a

Trailing P/E38.4

P25 n/aP50 n/aP75 n/a

ROE10.6

P25 n/aP50 n/aP75 n/a

ROIC7.2

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

S&P 500+0.8%

Nasdaq Composite-1.0%

Dow Jones Industrial Average+1.9%

Russell 2000+0.3%

All BVMF/ABTT34 indicators

Market & fundamental data

Available fields

239

Groups with data

Currency

USD

Showing 239 of 239 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	BRL
Country	United States
Country code	BR
Earnings date	2026-10-21
Employees	122,000
Employees change	7,000
Employees growth	6.09%
Enterprise value	BRL 1.1T
Exchange	Brazil Stock Exchange
Financial currency	USD
Financial report date	2026-09-30
First seen	2026-05-10
Fiscal year end	December
Founded	1888
Industry	Medical Devices
Is primary listing	No
ISIN number	BRABTTBDR007
Last earnings date	2026-10-21
Last refreshed	2026-10-28
Last stock split date	2022-11-21
Last stock split type	Forward
Market cap	BRL 953.9B
Price	BRL 46.10
Price currency	BRL
Sector	Healthcare
SIC code	3845
Stock price date	2026-10-27
Symbol	bvmf/ABTT34
Website	https://www.abbott.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	50.21x
Average P/E ratio (3Y)	27.41x
Average P/E ratio (5Y)	28.1x
Earnings yield	2.6%
EV/Earnings	45.5x
EV/EBIT	25.83x
EV/EBITDA	16.7x
EV/FCF	26.32x
EV/Sales	4.27x
FCF / EV yield	3.8%
FCF yield	4.39%
Forward P/E	17.55x
Graham number	18.4753
Graham upside	-59.92%
Lynch fair value	BRL 5.85
Lynch upside	-87.3%
P/(FCF - SBC) ratio	25.08x
P/(OCF - SBC) ratio	19.4x
P/B ratio	3.56x
P/E ratio	38.41x
P/FCF ratio	22.78x
P/OCF ratio	17.99x
P/S ratio	3.82x
Price/EBITDA ratio	15.41x
Sector forward P/E	11.33x
Sector P/E	41.97x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	16.55%
EBITDA margin	24.79%
Effective tax rate	28.36%
FCF margin	16.8%
Gross margin	57.08%
Operating margin	16.55%
Pretax margin	13.61%
Profit margin	9.75%
Profit per employee	BRL 210,664
Profitable quarters	34
Profitable years	35
Revenue per employee	BRL 2.2M
ROA	5.33%
ROA (5Y)	6.84%
ROCE	9.01%
ROE	10.58%
ROE (5Y)	19.7%
ROIC	7.25%
ROIC (5Y)	14.92%
SBC / revenue	1.54%
Tax / revenue	3.86%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	-66.24%
EPS growth (Q)	-43.69%
EPS growth (QoQ)	-0.12%
EPS growth 10Y	11.38%
EPS growth 3Y	-2.87%
EPS growth 5Y	-7.76%
EPS growth years	0
FCF growth	15.48%
FCF growth 3Y	12.55%
FCF growth 5Y	-1.97%
Gross profit growth	12.07%
Gross profit growth (Q)	17.95%
Gross profit growth 3Y	7.75%
Gross profit growth 5Y	2.62%
Net income growth	-66.37%
Net income growth (Q)	-44.04%
Net income growth (QoQ)	-0.86%
Net income growth 3Y	-3.11%
Net income growth 5Y	-8.3%
Net income growth years	0
OCF growth	9.61%
OCF growth 10Y	13.31%
OCF growth 3Y	9.95%
OCF growth 5Y	-1.4%
Operating income growth	-5.19%
Operating income growth (Q)	-33.06%
Operating income growth 3Y	5.37%
Operating income growth 5Y	-2.23%
Revenue growth	10%
Revenue growth (Q)	14.46%
Revenue growth (QoQ)	3.34%
Revenue growth 10Y	8.82%
Revenue growth 3Y	6.47%
Revenue growth 5Y	2.65%
Revenue growth quarters	11
Revenue growth years	2

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	BRL -11.1B
Depreciation and amortization	BRL 21.3B
EBIT	BRL 41.3B
EBITDA	BRL 61.9B
EPS	BRL 1.20
Financing cash flow	BRL 56.9B
Free cash flow	BRL 41.9B
Free cash flow minus SBC	BRL 38B
Gross profit	BRL 142.6B
Income taxes	BRL 9.6B
Investing cash flow	BRL -119.7B
Net borrowing	BRL 88.5B
Net cash flow	BRL -9.9B
Net income	BRL 24.2B
Operating cash flow minus SBC	BRL 49.2B
Operating income	BRL 41.3B
Revenue	BRL 249.8B
Stock-based compensation	BRL 3.8B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	BRL 153.00
Debt / EBITDA	2.65
Debt / equity	0.63
Debt / FCF	4.05
Interest coverage	7.87
Net cash (debt)	BRL -140.5B
Net cash / market cap	-14.72%
Net debt / EBITDA	2.27
Net debt / equity	0.52
Net debt / FCF	3.35
Piotroski F-Score	5
Shareholders' equity	BRL 268.1B
Tangible book value	BRL -7B
Tangible book value per share	BRL -4.03
Total cash	BRL 29B
Total debt	BRL 169.5B
WACC	6.67%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.48
Current ratio	1.38
Inventory turnover	2.82
Quick ratio	0.8
Working capital	BRL 35.9B

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	0.25%
Dividend growth	11.28%
Dividend growth (10Y)	5.07%
Dividend growth (3Y)	7.26%
Dividend growth (5Y)	7.07%
Dividend growth years	6
Dividend payment date	2026-11-23
Dividend payment years	15
Dividend payout frequency	Quarterly
Dividend per share	BRL 0.72
Dividend yield	1.57%
Ex-dividend date	2026-10-14
Last dividend	BRL 0.04
Payout ratio	60.32%
Shareholder yield	1.81%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	343.14%
10Y return CAGR	17.68%
10Y total return	409.03%
150-day SMA	BRL 42.04
1D price change	-2.21%
1M price change	5.01%
1M total return	5.46%
1W price change	5.64%
1W total return	5.64%
1Y price change	-18.8%
1Y return CAGR	-17.45%
1Y total return	-17.44%
20-day SMA	BRL 43.04
200-day SMA	BRL 44.07
3M price change	5.56%
3M total return	6.01%
3Y price change	17.69%
3Y return CAGR	7.08%
3Y total return	22.79%
50-day SMA	BRL 45.21
50-day SMA vs 200-day SMA	50over200
52-week high	BRL 58.85
52-week high date	2025-12-30
52-week low	BRL 33.50
52-week low date	2026-05-11
5Y price change	-22.93%
5Y return CAGR	-3.8%
5Y total return	-17.62%
6M price change	20.71%
6M total return	21.8%
All-time high	BRL 67.65
All-time high date	2025-02-28
All-time low	BRL 5.57
All-time low date	2013-01-28
Average true range (ATR)	BRL 1.61
Average volume	570
Beta (5Y)	0.58
Change from 52-week high	-21.67%
Change from 52-week low	37.61%
Change from all-time high	-31.86%
Change from all-time low	728.09%
Change from open	-1.07%
Day's gap	-1.15%
Dollar volume	BRL 4,011
High price	BRL 46.60
Low price	BRL 45.85
Monthly RSI	46.51
Open price	BRL 46.60
Position in 52-week range	33.33%
Previous close	BRL 47.14
Price vs 150-day SMA	9.67%
Price vs 20-day SMA	7.11%
Price vs 200-day SMA	4.61%
Price vs 50-day SMA	1.98%
Relative volume	0.15
RSI	57.59
Sharpe ratio	-0.47
Sharpe ratio (3Y)	0.11
Sharpe ratio (5Y)	-0.03
Sortino ratio	-0.56
Sortino ratio (3Y)	0.34
Sortino ratio (5Y)	0.14
Volume	87
Weekly RSI	53.61
YTD price change	-19.63%
YTD total return	-18.29%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1.7B
Shares change (QoQ)	-0.29%
Shares change (YoY)	-0.25%
Shares held by insiders	0.5%
Shares held by institutions	80.98%
Short ratio	1.9 days

Deeper analysis on BVMF/ABTT34

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Scorecard

Six-factor overlay and 9-category weighted scorecard.

→

Recommendation

Final action, action steps, opportunity, and biggest risk.

→

Perspectives

Growth, value, and income investor reads.

→

Frequently asked questions

About this BVMF/ABTT34 report

Is a complete BVMF/ABTT34 research report available?

No complete published report is available for bvmf/ABTT34 (BVMF/ABTT34) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Market cap

953.9B

Revenue (ttm)

249.8B

Net income (ttm)

24.2B

EPS (ttm)

R$1.20

P/E (trailing)

38.4x

P/E (forward)

17.5x

Dividend

R$0.72 (1.57%)

Volume

Beta

0.58

Metric

Value

Amount currency

BRL

Country

United States

Country code

Earnings date

2026-10-21

Employees

122,000

Employees change

7,000

Employees growth

6.09%

Enterprise value

BRL 1.1T

Exchange

Brazil Stock Exchange

Financial currency

USD

Financial report date

2026-09-30

First seen

2026-05-10

Fiscal year end

December

Founded

1888

Industry

Medical Devices

Is primary listing

ISIN number

BRABTTBDR007

Last earnings date

2026-10-21

Last refreshed

2026-10-28

Last stock split date

2022-11-21

Last stock split type

Forward

Market cap

BRL 953.9B

Price

BRL 46.10

Price currency

BRL

Sector

Healthcare

SIC code

3845

Stock price date

2026-10-27

Symbol

bvmf/ABTT34

Website

https://www.abbott.com

Metric

Value

Average P/E ratio (10Y)

50.21x

Average P/E ratio (3Y)

27.41x

Average P/E ratio (5Y)

28.1x

Earnings yield

2.6%

EV/Earnings

45.5x

EV/EBIT

25.83x

EV/EBITDA

16.7x

EV/FCF

26.32x

EV/Sales

4.27x

FCF / EV yield

3.8%

FCF yield

4.39%

Forward P/E

17.55x

Graham number

18.4753

Graham upside

-59.92%

Lynch fair value

BRL 5.85

Lynch upside

-87.3%

P/(FCF - SBC) ratio

25.08x

P/(OCF - SBC) ratio

19.4x

P/B ratio

3.56x

P/E ratio

38.41x

P/FCF ratio

22.78x

P/OCF ratio

17.99x

P/S ratio

3.82x

Price/EBITDA ratio

15.41x

Sector forward P/E

11.33x

Sector P/E

41.97x

Metric

Value

EBIT margin

16.55%

EBITDA margin

24.79%

Effective tax rate

28.36%

FCF margin

16.8%

Gross margin

57.08%

Operating margin

16.55%

Pretax margin

13.61%

Profit margin

9.75%

Profit per employee

BRL 210,664

Profitable quarters

Profitable years

Revenue per employee

BRL 2.2M

ROA

5.33%

ROA (5Y)

6.84%

ROCE

9.01%

ROE

10.58%

ROE (5Y)

19.7%

ROIC

7.25%

ROIC (5Y)

14.92%

SBC / revenue

1.54%

Tax / revenue

3.86%

Metric

Value

EPS growth

-66.24%

EPS growth (Q)

-43.69%

EPS growth (QoQ)

-0.12%

EPS growth 10Y

11.38%

EPS growth 3Y

-2.87%

EPS growth 5Y

-7.76%

EPS growth years

FCF growth

15.48%

FCF growth 3Y

12.55%

FCF growth 5Y

-1.97%

Gross profit growth

12.07%

Gross profit growth (Q)

17.95%

Gross profit growth 3Y

7.75%

Gross profit growth 5Y

2.62%

Net income growth

-66.37%

Net income growth (Q)

-44.04%

Net income growth (QoQ)

-0.86%

Net income growth 3Y

-3.11%

Net income growth 5Y

-8.3%

Net income growth years

OCF growth

9.61%

OCF growth 10Y

13.31%

OCF growth 3Y

9.95%

OCF growth 5Y

-1.4%

Operating income growth

-5.19%

Operating income growth (Q)

-33.06%

Operating income growth 3Y

5.37%

Operating income growth 5Y

-2.23%

Revenue growth

10%

Revenue growth (Q)

14.46%

Revenue growth (QoQ)

3.34%

Revenue growth 10Y

8.82%

Revenue growth 3Y

6.47%

Revenue growth 5Y

2.65%

Revenue growth quarters

Revenue growth years

Metric

Value

Capital expenditures

BRL -11.1B

Depreciation and amortization

BRL 21.3B

EBIT

BRL 41.3B

EBITDA

BRL 61.9B

EPS

BRL 1.20

Financing cash flow

BRL 56.9B

Free cash flow

BRL 41.9B

Free cash flow minus SBC

BRL 38B

Gross profit

BRL 142.6B

Income taxes

BRL 9.6B

Investing cash flow

BRL -119.7B

Net borrowing

BRL 88.5B

Net cash flow

BRL -9.9B

Net income

BRL 24.2B

Operating cash flow minus SBC

BRL 49.2B

Operating income

BRL 41.3B

Revenue

BRL 249.8B

Stock-based compensation

BRL 3.8B

Metric

Value

Book value per share

BRL 153.00

Debt / EBITDA

2.65

Debt / equity

0.63

Debt / FCF

4.05

Interest coverage

7.87

Net cash (debt)

BRL -140.5B

Net cash / market cap

-14.72%

Net debt / EBITDA

2.27

Net debt / equity

0.52

Net debt / FCF

3.35

Piotroski F-Score

Shareholders' equity

BRL 268.1B

Tangible book value

BRL -7B

Tangible book value per share

BRL -4.03

Total cash

BRL 29B

Total debt

BRL 169.5B

WACC

6.67%

Metric

Value

Asset turnover

0.48

Current ratio

1.38

Inventory turnover

2.82

Quick ratio

0.8

Working capital

BRL 35.9B

Metric

Value

Buyback yield / dilution

0.25%

Dividend growth

11.28%

Dividend growth (10Y)

5.07%

Dividend growth (3Y)

7.26%

Dividend growth (5Y)

7.07%

Dividend growth years

Dividend payment date

2026-11-23

Dividend payment years

Dividend payout frequency

Quarterly

Dividend per share

BRL 0.72

Dividend yield

1.57%

Ex-dividend date

2026-10-14

Last dividend

BRL 0.04

Payout ratio

60.32%

Shareholder yield

1.81%

Metric

Value

10Y price change

343.14%

10Y return CAGR

17.68%

10Y total return

409.03%

150-day SMA

BRL 42.04

1D price change

-2.21%

1M price change

5.01%

1M total return

5.46%

1W price change

5.64%

1W total return

5.64%

1Y price change

-18.8%

1Y return CAGR

-17.45%

1Y total return

-17.44%

20-day SMA

BRL 43.04

200-day SMA

BRL 44.07

3M price change

5.56%

3M total return

6.01%

3Y price change

17.69%

3Y return CAGR

7.08%

3Y total return

22.79%

50-day SMA

BRL 45.21

50-day SMA vs 200-day SMA

50over200

52-week high

BRL 58.85

52-week high date

2025-12-30

52-week low

BRL 33.50

52-week low date

2026-05-11

5Y price change

-22.93%

5Y return CAGR

-3.8%

5Y total return

-17.62%

6M price change

20.71%

6M total return

21.8%

All-time high

BRL 67.65

All-time high date

2025-02-28

All-time low

BRL 5.57

All-time low date

2013-01-28

Average true range (ATR)

BRL 1.61

Average volume

570

Beta (5Y)

0.58

Change from 52-week high

-21.67%

Change from 52-week low

37.61%

Change from all-time high

-31.86%

Change from all-time low

728.09%

Change from open

-1.07%

Day's gap

-1.15%

Dollar volume

BRL 4,011

High price

BRL 46.60

Low price

BRL 45.85

Monthly RSI

46.51

Open price

BRL 46.60

Position in 52-week range

33.33%

Previous close

BRL 47.14

Price vs 150-day SMA

9.67%

Price vs 20-day SMA

7.11%

Price vs 200-day SMA

4.61%

Price vs 50-day SMA

1.98%

Relative volume

0.15

RSI

57.59

Sharpe ratio

-0.47

Sharpe ratio (3Y)

0.11

Sharpe ratio (5Y)

-0.03

Sortino ratio

-0.56

Sortino ratio (3Y)

0.34

Sortino ratio (5Y)

0.14

Volume

Weekly RSI

53.61

YTD price change

-19.63%

YTD total return

-18.29%

Metric

Value

Float

1.7B

Shares change (QoQ)

-0.29%

Shares change (YoY)

-0.25%

Shares held by insiders

0.5%

Shares held by institutions

80.98%

Short ratio

1.9 days

BVMF/ABTT34 (BVMF/ABTT34)

Price

Financial snapshot

Fair-value bridge

Latest news · BVMF/ABTT34

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BVMF/ABTT34 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BVMF/ABTT34

Frequently asked questions

BVMF/ABTT34 (BVMF/ABTT34)

Price

Financial snapshot

Fair-value bridge

Latest news · BVMF/ABTT34

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BVMF/ABTT34 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BVMF/ABTT34

Frequently asked questions